Clinical Advances in Myeloma National Conference 2018

The clinical advances in multiple myeloma have made great strides over the past few years, with the advent of novel therapeutic drugs dramatically improving both remission and survival rates in myeloma patients. There is still however a great deal of research currently underway investigating both current and emerging treatments in order to develop the most effective clinical practices in the treatment of multiple myeloma. Myeloma 2018 is a one day CPD certified conference, in association with The British Journal of Hospital Medicine, that aims to provide healthcare professionals with the most up-to-date clinical knowledge regarding the diagnosis, treatment and management of myeloma. This conference also provides the unique opportunity for clinicians to discuss the current controversial topics in myeloma in interactive case studies and panel discussions led by experts in the field.